Waqtola Cheneke
Overview
Explore the profile of Waqtola Cheneke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ibrahim T, Russel W, Getachew A, Zemene E, Cheneke W, Taye B
BMC Infect Dis
. 2024 Sep;
24(1):922.
PMID: 39237908
Background: Previous studies have implicated the role of H. pylori infection in developing the metabolic syndrome. However, findings remain contradictory, and data from developing countries are scarce. Methods: We employed...
2.
Addisu B, Bekele S, Wube T, Hirigo A, Cheneke W
BMC Cardiovasc Disord
. 2023 Jun;
23(1):321.
PMID: 37355585
Background: Cardiovascular disease is a cluster of illnesses that affect the heart and blood vessels. Dyslipidemia is the most common risk factor for cardiovascular disease, causing more than 4 million...
3.
Gebregzabher E, Tesfaye F, Cheneke W, Negesso A, Kedida G
Hum Resour Health
. 2023 Jun;
21(1):47.
PMID: 37340429
Background: Continuing professional development (CPD) is required for health workers in practice to update knowledge and skills regularly to match the changing complexity of healthcare needs. The objective of this...
4.
Befekadu A, Cheneke W, Kebebe D, Gudeta T
J Pharm Policy Pract
. 2020 Sep;
13:49.
PMID: 32908670
Background: Maintaining an efficient and effective inventory management system ensures a reliable supply of laboratory commodities. The aim of this study was, therefore, to assess the performance of inventory management...
5.
Abdu A, Cheneke W, Adem M, Belete R, Getachew A
Int J Gen Med
. 2020 Jul;
13:311-321.
PMID: 32606896
Background: Dyslipidemia is a group of plasma lipid and lipoprotein abnormality that is metabolically associated, and it is categorized by low HDL-C and increased LDL-C, TGs, and total cholesterol (TC)...
6.
Getachew A, Cheneke W, Asres Y, Bekele S, Kebede E
J Trop Med
. 2019 Apr;
2019:5954313.
PMID: 30941182
Background: Medical laboratories play essential roles in measurement of analyte in clinical sample for the diagnosis and monitoring of diseases. Thus, data generated from the laboratory have to be reliable...
7.
Sufa B, Abebe G, Cheneke W
BMC Res Notes
. 2019 Mar;
12(1):120.
PMID: 30832721
Objective: Dyslipidemia is abnormal amount of lipid in blood. Hormonal contraceptives affect lipid metabolism and can enhance the risk of vascular disease like atherosclerosis. In Harar, among contraceptive users, biochemical...
8.
Bimerew L, Demie T, Eskinder K, Getachew A, Bekele S, Cheneke W, et al.
SAGE Open Med
. 2018 Nov;
6:2050312118807626.
PMID: 30397473
Background: Clinical laboratory reference intervals are an important tool to identify abnormal laboratory test results. The generating of hematological parameters reference intervals for local population is very crucial to improve...
9.
Asaye S, Bekele S, Tolessa D, Cheneke W
Diabetes Metab Syndr
. 2018 May;
12(5):753-760.
PMID: 29729979
Background: Metabolic syndrome is a multisystem disorder which coined to describe the recognized clustering of metabolic and cardiovascular abnormalities including obesity, hypertension, dyslipidemia, and abnormalities of glucose homeostasis. Objective: To...
10.
Abda E, Hamza L, Tessema F, Cheneke W
Diabetes Metab Syndr Obes
. 2016 Mar;
9:47-53.
PMID: 27019600
Background: Developing countries are now experiencing the epidemiologic transition, whereby the burden of chronic diseases, like metabolic syndrome, is increasing. However, no study had previously been conducted to show the...